Metabolic profiling of human lung cancer tissue by1H high resolution magic angle spinning (HRMAS) NMR spectroscopy

Journal of Proteome Research

Volumn 9, Issue 1, 2010, Pages 319-332

  Rocha, Cláudia M ^a   Barros, António S ^b   Gil, Ana M ^a   Goodfellow, Brian J ^a,c   Humpfer, Eberhard ^d   Spraul, Manfred ^d   Carreira, Isabel M ^c,e   Melo, Joana B ^e   Bernardo, João ^c   Gomes, Ana ^c   Sousa, Vitor ^c   Carvalho, Lina ^c   Duarte, Iola F ^a,c  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b UNIVERSITY OF AVEIRO   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d BRUKER BIOSPIN GMBH   (Germany)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

HRMAS; Lung cancer; Metabolic composition; Multivariate analysis; NMR spectroscopy

Indexed keywords

ACETIC ACID; ADENOSINE; AMINO ACID; GLUCOSE; GLYCEROPHOSPHORYLCHOLINE; INOSINE; INOSITOL; LACTIC ACID; PHOSPHORYLCHOLINE;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; LUNG CANCER; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THERMOSTABILITY; TISSUE METABOLISM;

ADULT; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; METABOLOME; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PRINCIPAL COMPONENT ANALYSIS;

EID: 73649147390     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr9006574     Document Type: Article

References (41)

1. Parkin, D. M.; Bray, F.; Ferlay, J.; Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55 (2), 74-108.
2. Pirozynski, M. 100 years of lung cancer. Resp. Med. 2006, 100 (12), 2073-2084.
3. Travis, W. D.; Brambilla, E.; Müller-Hermelink, H. K.; Harris, C. World Health Organization Classification of Tumors; Tumours of the Lung, Pleura, Thymus and Heart. IARC Press: Lyon, France, 2004.
4. Maxwell, R. J.; Martinez-Perez, I.; Cerdan, S.; Cabanas, M. E.; Arus, C.; Moreno, A.; Capdevila, A.; Ferrer, E.; Bartomeus, F.; Aparicio, A.; Conesa, G.; Roda, J. M.; Carceller, F.; Pascual, J. M.; Howells, S. L.; Mazucco, R.; Griffiths, J. R. Pattern recognition analysis of 1H NMR spectra from perchloric acid extracts of human brain tumor biopsies. Magn. Reson. Med. 1998, 39 (6), 869-877.
5. Lehnhardt, F.-G.; Rohn, G.; Ernestus, R.-I.; Grune, M.; Hoehn, M. 1Hand 31P-NMR of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water-soluble and lipophilic spectral components. NMR Biomed. 2001, 14 (5), 307-317.
6. Gribbestad, I. S.; Petersen, S. B.; Hans, E. F.; Kvinnsland, S.; Krane, J. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed. 1994, 7 (4), 181-194.
7. Beckonert, O. P.; Monnerjahn, J.; Bonk, U.; Leibfritz, D. Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps. NMR Biomed. 2003, 16 (1), 1-11.
8. Moreno, A.; Arus, C. Quantitative and qualitative characterization of 1H NMRspectra of colon tumors, normal mucosa and their perchloric acid extracts: decreased levels of myo-inositol in tumors can be detected in intact biopsies. NMR Biomed. 1996, 9 (1), 33-45.
9. Hanaoka, H.; Yoshioka, Y.; Ito, I.; Niitu, K.; Yasuda, N. In vitro characterization of lung cancers by the use of 1H nuclear magnetic resonance spectroscopy of tissue extracts and discriminant factor analysis. Magn. Reson. Med. 1993, 29 (4), 436-440.
10. Guo, J.; Higashi, K.; Yokota, H.; Nagao, Y.; Ueda, Y.; Kodama, Y.; Oguchi, M.; Taki, S.; Tonami, H.; Yamamoto, I. In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma. J. Nucl. Med. 2004, 45 (8), 1334-1339.
11. Yokota, H.; Guo, J.; Matoba, M.; Higashi, K.; Tonami, H.; Nagao, Y. Lactate, choline and creatine levels measured by vitro 1H-MRS as prognostic parameters in patients with non-small-cell lung cancer. J. Magn. Reson. Imaging 2007, 25 (5), 992-999.
12. Lindon, J. C.; Beckonert, O. P.; Holmes, E.; Nicholson, J. K. Highresolution magic angle spinning NMR spectroscopy: Application to biomedical studies. Prog. Nucl. Magn. Reson. Spectrosc. 2009. doi:10.1016/j.pnmrs. 2008.11.004.
13. Sitter, B.; Bathen, T. F.; Tessem, M.-B.; Gribbestad, I. S. High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer. Prog. Nucl. Magn. Reson. Spectrosc. 2009, 54 (3-4), 239-254.
14. Swanson, M. G.; Vigneron, D. B.; Tabatabai, Z. L.; Males, R. G.; Schmitt, L.; Carroll, P. R.; James, J. K.; Hurd, R. E.; Kurhanewicz, J. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn. Reson. Med. 2003, 50 (5), 944-954.
15. Tugnoli, V.; Schenetti, L.; Mucci, A.; Parenti, F.; Cagnoli, R.; Righi, V.; Trinchero, A.; Nocetti, L.; Toraci, C.; Mavilla, L.; Trentini, G.; Zunarelli, E.; Tosi, M. R. Ex vivo HR-MAS MRS of human meningiomas: A comparison with in vivo 1H MR spectra. Int. J. Mol. Med. 2006, 18 (5), 859-869.
16. Mountford, C.; Lean, C.; Malycha, P.; Russell, P. Proton spectroscopy provides accurate pathology on biopsy and in vivo. J. Magn. Reson. Imaging 2006, 24 (3), 459-477.
17. Thomas, M. A.; Lipnick, S.; Velan, S. S.; Liu, X.; Banakar, S.; Binesh, N.; Ramadan, S.; Ambrosio, A.; Raylman, R. R.; Sayre, J.; DeBruhl, N.; Bassett, L. Investigation of breast cancer using two-dimensional MRS. NMR Biomed. 2009, 22 (1), 77-91.
18. Wilson, M.; Davies, N. P.; Grundyd, R. G.; Peet, A. C. A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1H HR-MAS for childhood brain tumors. NMR Biomed. 2009, 22 (2), 213-219.
19. Sitter, B.; Lundgren, S.; Bathen, T. F.; Halgunset, J.; Fjosne, H. E.; Gribbestad, I. S. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed. 2006, 19 (1), 30-40.
20. Bathen, T. F.; Jensen, L. R.; Sitter, B.; Fjosne, H. E.; Halgunset, J.; Axelson, D. E.; Gribbestad, I. S.; Lundgren, S. MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status. Breast Cancer Res. Treat. 2007, 104 (2), 181-189.
21. Erb, G.; Elbayed, K.; Piotto, M.; Raya, J.; Neuville, A.; Mohr, M.; Maitrot, D.; Kehrli, P.; Namer, I. J. Toward improved grading of malignancy in oligodendrogliomas using metabolomics. Magn. Reson. Med. 2008, 59 (5), 959-965.
22. Monleon, D.; Morales, J. M.; Gonzalez-Darder, J.; Talamantes, F.; Cortes, O.; Gil-Benso, R.; Lopez-Gines, C.; Cerda-Nicolas, M.; Celda, B. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling. J. Proteome Res. 2008, 7 (7), 2882-2888.
23. Cheng, L. L.; Burns, M. A.; Taylor, J. L.; He, W.; Halpern, E. F.; McDougal, W. S.; Wu, C.-L. Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res. 2005, 65 (8), 3030-3034.
24. Tessem, M.-B.; Swanson, M. G.; Keshari, K. R.; Albers, M. J.; Joun, D.; Tabatabai, Z. L.; Simko, J. P.; Shinohara, K.; Nelson, S. J.; Vigneron, D. B.; Gribbestad, I. S.; Kurhanewicz, J. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn. Reson. Med. 2008, 60 (3), 510-516.
25. van Asten, J. J. A.; Cuijpers, V.; Hulsbergen-van de Kaa, C.; Soede-Huijbregts, C.; Witjes, J. A.; Verhofstad, A.; Heerschap, A. High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies. MAGMA 2008, 21 (6), 435-442.
26. Sitter, B.; Bathen, T. F.; Hagen, B.; Arentz, C.; Skjeldestad, F. E.; Gribbestad, I. S. Cervical cancer tissue characterized by highresolution magic angle spinning MR spectroscopy. MAGMA 2004, 16 (4), 174-181.
27. Mahon, M. M.; deSouza, N. M.; Dina, R.; Soutter, W. P.; McIndoe, G. A.; Williams, A. D.; Cox, I. J. Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study. NMR Biomed. 2004, 17 (3), 144-153.
28. De Silva, S. S.; Payne, G. S.; Thomas, V.; Carter, P. G.; Ind, T. E. J.; deSouza, N. M. Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using 1H and 31P magic angle spinning MRS of intact tissue. NMR Biomed. 2009, 22 (2), 191-198.
29. Chan, E. C. Y.; Koh, P. K.; Mal, M.; Cheah, P. Y.; Eu, K. W.; Backshall, A.; Cavill, R.; Nicholson, J. K.; Keun, H. C. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J. Proteome Res. 2009, 8 (1), 352-361.
30. Yang, Y.; Li, C.; Nie, X.; Feng, X.; Chen, W.; Yue, Y.; Tang, H.; Deng, F. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis. J. Proteome Res. 2007, 6 (7), 2605-2614.
31. Tate, A. R.; Foxall, P. J. D.; Elaine Holmes; Moka, D.; Spraul, M.; Nicholson, J. K.; Lindon, J. C. Distinction between normal and renal cell carcinoma kidney cortical biopsy samples using pattern recognition of 1H magic angle spinning (MAS) NMR spectra. NMR Biomed. 2000, 13 (2), 64-71.
32. Righi, V.; Mucci, A.; Schenetti, L.; Tosi, M. R.; Grigioni, W. F.; Corti, B.; Bertaccini, A.; Franceschelli, A.; Sanguedolce, F.; Schiavina, R.; Martorana, G.; Tugnoli, V. Ex vivo HR-MAS magnetic resonance spectroscopy of normal and malignant human renal tissues. Anticancer Res. 2007, 27 (5A), 3195-3204.
33. Tugnoli, V.; Mucci, A.; Schenetti, L.; Righi, V.; Calabrese, C.; Fabbri, A.; Di Febo, G.; Tosi, M. R. Ex vivo HR-MAS magnetic resonance spectroscopy of human gastric adenocarcinomas: a comparison with healthy gastric mucosa. Oncol. Rep. 2006, 16 (3), 543-553.
34. Jordan, K. W.; Adkins, C. B.; Su, L.; Halpern, E. F.; Mark, E. J.; Christiani, D. C.; Cheng, L. L. Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissue-serum pairs. Lung Cancer 2009. doi:10.1016/j.lungcan.2009.05.012.
35. Filzmoser, P.; Maronna, R.; Werner, M. Outlier identification in high dimensions. Comput. Stat. Data Anal. 2008, 1694-1711.
36. Barros A. S. Contribution à lasélection et la comparaison de variables caractéristiques. [Ph.D. Thesis]; Institut National Agronomique Paris-Grignon: Paris, France, 1999; p 191.
37. R development core team, R: A language environment for statistical computing (http://www.R-project.org), 2009, Vienna, Austria.
38. Swanson, M. G.; Zektzer, A. S.; Tabatabai, Z. L.; Simko, J.; Jarso, S.; Keshari, K. R.; Schmitt, L.; Carroll, P. R.; Shinohara, K.; Vigneron, D. B.; Kurhanewicz, J. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn. Reson. Med. 2006, 55 (5), 1257-1264.
39. Opstad, K. S.; Bell, B. A.; Griffiths, J. R.; Howe, F. A. An assessment of the effects of sample ischaemia and spinning time on the metabolic profile of brain tumor biopsy specimens as determined by high-resolution magic angle spinning 1H NMR. NMR Biomed. 2008, 21 (10), 1138-1147.
40. Hakumaki, J. M.; Kappinen, R. A. 1H NMR visible lipids in the life and death of cells. TIBS 2000, 25, 357-362.
41. Glunde, K.; Ackerstaff, E.; Mori, N.; Jacobs, M. A.; Bhujwalla, Z. M. Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. Mol. Pharmacol. 2006, 3 (5), 496-506.